Michel Aurrand-Lions

12PUBLICATIONS
59CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Haematological tumoursMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 23, 2026
Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.

|Aug 13, 2025
Junctional adhesion molecule-C: A multifunctional mediator of cell adhesion.

Klaus Ebnet, Michel Aurrand-Lions

|Oct 29, 2024
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

Vincent Rondeau, Maria Kalogeraki, Lilian Roland

|Jul 02, 2024
Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML.

Julien M P Grenier, Céline Testut, Matthieu Bal

|Oct 11, 2023
Downregulation of stromal syntenin sustains AML development.

Raphael Leblanc, Rania Ghossoub, Armelle Goubard

|Apr 12, 2023
WHIM Syndrome-linked CXCR4 mutations drive osteoporosis.

Adrienne Anginot, Julie Nguyen, Zeina Abou Nader

Pageof 2

Frequent Collaborators

3 joint publications

Maria De Grandis

3 joint publications

Jean-Paul Borg

3 joint publications

Stéphane Jc Mancini

2 joint publications

Norbert Vey